- Home
- NIE vs MPLT Comparison
NIE vs MPLT Comparison
Compare NIE & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NIE | MPLT |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 704.1M | 811.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NIE | MPLT |
|---|---|---|
| Price | $23.62 | $18.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $31.80 |
| AVG Volume (30 Days) | 50.9K | ★ 155.5K |
| Earning Date | 01-01-0001 | 03-26-2026 |
| Dividend Yield | ★ 9.04% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.54 | $12.24 |
| 52 Week High | $26.00 | $21.55 |
Technical Indicators
Market Signals| Indicator | NIE | MPLT |
|---|---|---|
| Relative Strength Index (RSI) | 30.30 | 47.64 |
| Support Level | $22.74 | $16.17 |
| Resistance Level | $23.81 | $20.73 |
| Average True Range (ATR) | 0.35 | 1.25 |
| MACD | -0.09 | -0.12 |
| Stochastic Oscillator | 18.62 | 25.41 |
Price Performance
Historical ComparisonAbout NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.
About MPLT MapLight Therapeutics Inc.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.